Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 152
Selected: 0
NCT IDTitle
NCT07676383Precision Navigation to Improve Community Cancer Screening Participation
NCT05198154ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
NCT01470495Combined Treatment of RFA and Sorafenib on Recurrent HCC
NCT02717923A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer
NCT07083687Lorlatinib in ROS1+ NSCLC With Brain Metastasis
NCT05351346Genotype-guided Treatment in DLBCL
NCT01285219A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy
NCT03994744Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC
NCT01271439Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma
NCT03503136Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
NCT03624309Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer
NCT03286920Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT07005999Interventional Ablation for Early-stage Lung Cancer
NCT06486545Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer
NCT04407988Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer
NCT02876861Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC
NCT07654634Precision Antithrombotic Therapy
NCT0655759018F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT05907447A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
NCT07674368Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed
NCT06031376Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
NCT06543108Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
NCT03116984A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC
NCT07163481A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors
NCT02971345Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
NCT04193319Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects
NCT06047184Phase I Study of BEBT-209 in Women With Advanced Breast Cancer
NCT03880695Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT05151549A Study of Carilizumab Combined With Concurrent Chemoradiotherapy
NCT05940532A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
NCT06011330Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer
NCT05942768Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
NCT05872880TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.
NCT05244499Evidence-based Leadership in Nurse Leaders-CH
NCT07590024RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma
NCT05107011Phase I/II Clinical Trial of LBL-015 for Injection
NCT05079074Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT06321939Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
NCT05001971Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
NCT06061146Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC
NCT06327698Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
NCT06712888Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT06440954Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases
NCT05206656Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer
NCT07687225Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases
NCT06737913HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
NCT03351062Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT05512286Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction
NCT04636762A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
NCT05268172IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites